Endocrine drugs (insulin, thyroid medications) US Medical PG Practice Questions and MCQs
Practice US Medical PG questions for Endocrine drugs (insulin, thyroid medications). These multiple choice questions (MCQs) cover important concepts and help you prepare for your exams.
Endocrine drugs (insulin, thyroid medications) US Medical PG Question 1: A 22-year-old woman with type 1 diabetes mellitus and mild asthma comes to the physician for a follow-up examination. She has had several episodes of sweating, dizziness, and nausea in the past 2 months that occur during the day and always resolve after she drinks orange juice. She is compliant with her diet and insulin regimen. The physician recommends lowering her insulin dose in certain situations. This recommendation is most important in which of the following situations?
- A. After a stressful exam
- B. During a viral infection
- C. Before exercise (Correct Answer)
- D. After large meals
- E. During pregnancy
Endocrine drugs (insulin, thyroid medications) Explanation: ***Before exercise***
- Exercise increases **glucose utilization** by muscles, which can lead to **hypoglycemia** in individuals taking insulin if the dose isn't adjusted.
- The patient's symptoms (sweating, dizziness, nausea) are classic for **hypoglycemia**, which resolves with sugar intake (orange juice).
*After a stressful exam*
- **Stress** typically elevates **counter-regulatory hormones** (e.g., cortisol, epinephrine), which can increase blood glucose levels rather than cause hypoglycemia.
- An insulin dose reduction is usually not necessary and could lead to **hyperglycemia** in this situation.
*During a viral infection*
- Infections, even viral ones, often trigger the release of **stress hormones**, increasing glucose production and leading to **hyperglycemia** and increased insulin requirements.
- Insulin doses usually need to be *increased*, not decreased, during illness to manage elevated blood sugar.
*After large meals*
- Large meals, especially those rich in carbohydrates, would necessitate an **increased or consistent insulin dose** to cover the glucose intake and prevent **postprandial hyperglycemia**.
- Reducing insulin after a large meal would likely lead to uncontrolled high blood sugar rather than prevent hypoglycemia.
*During pregnancy*
- While insulin requirements can fluctuate throughout pregnancy, they generally **increase** in the second and third trimesters due to increased **insulin resistance**.
- Reducing insulin during pregnancy without careful monitoring could lead to uncontrolled **hyperglycemia**, posing risks to both mother and fetus.
Endocrine drugs (insulin, thyroid medications) US Medical PG Question 2: A 13-year-old girl presents after losing consciousness during class 30 minutes ago. According to her friends, she was doing okay since morning, and nobody noticed anything abnormal. The patient’s mother says that her daughter does not have any medical conditions. She also says that the patient has always been healthy but has recently lost weight even though she was eating as usual. Her vital signs are a blood pressure of 100/78 mm Hg, a pulse of 89/min, and a temperature of 37.2°C (99.0°F). Her breathing is rapid but shallow. Fingerstick glucose is 300 mg/dL. Blood is drawn for additional lab tests, and she is started on intravenous insulin and normal saline. Which of the following HLA subtypes is associated with this patient’s most likely diagnosis?
- A. DR3 (Correct Answer)
- B. A3
- C. B8
- D. DR5
- E. B27
Endocrine drugs (insulin, thyroid medications) Explanation: ***DR3***
- The patient's presentation with **recent weight loss despite normal eating**, rapid but shallow breathing (**Kussmaul respiration** hinting at **metabolic acidosis**), elevated blood glucose (300 mg/dL), and loss of consciousness strongly suggests **Type 1 Diabetes Mellitus (T1DM)** presenting as **diabetic ketoacidosis (DKA)**.
- **HLA-DR3** and **HLA-DR4** are the primary genetic markers most strongly associated with an increased susceptibility to Type 1 Diabetes Mellitus, an **autoimmune disease** affecting pancreatic beta cells.
- **HLA-DR3** is the most direct answer as it is one of the two strongest HLA-DR associations with T1DM.
*A3*
- **HLA-A3** is primarily associated with **hemochromatosis**, a disorder of iron metabolism, and is not a common genetic marker for Type 1 Diabetes Mellitus.
- The symptoms described in the patient (weight loss, hyperglycemia, DKA) are not characteristic of hemochromatosis.
*B8*
- **HLA-B8** is actually associated with Type 1 Diabetes Mellitus as part of the **extended haplotype A1-B8-DR3**, which shows strong linkage disequilibrium.
- However, **HLA-B8 is not as directly or specifically associated with T1DM** as the HLA-DR subtypes (DR3 and DR4), which are considered the primary genetic markers.
- When asking about HLA subtypes associated with T1DM, **DR3 or DR4** are the best answers as they show the strongest and most direct association.
- HLA-B8 is also associated with other autoimmune conditions like **myasthenia gravis** and **Graves' disease**.
*DR5*
- While part of the **HLA-DR family**, **HLA-DR5** is less commonly associated with **Type 1 Diabetes Mellitus** compared to DR3 and DR4.
- This subtype is more frequently linked with conditions like **pernicious anemia** or increased risk of certain infections.
*B27*
- **HLA-B27** is strongly associated with **seronegative spondyloarthropathies**, such as **ankylosing spondylitis** and **reactive arthritis**.
- It has no known direct association with **Type 1 Diabetes Mellitus**.
Endocrine drugs (insulin, thyroid medications) US Medical PG Question 3: A 22-year-old woman with a history of type I diabetes mellitus presents to the emergency department with nausea, vomiting, and drowsiness for the past day. Her temperature is 98.3°F (36.8°C), blood pressure is 114/74 mmHg, pulse is 120/min, respirations are 27/min, and oxygen saturation is 100% on room air. Physical exam is notable for a confused and lethargic young woman. Initial laboratory values are notable for the findings below.
Serum:
Na+: 139 mEq/L
Cl-: 100 mEq/L
K+: 2.9 mEq/L
HCO3-: 9 mEq/L
BUN: 20 mg/dL
Glucose: 599 mg/dL
Creatinine: 1.1 mg/dL
Ca2+: 10.2 mg/dL
AST: 12 U/L
ALT: 10 U/L
An initial ECG is notable for sinus tachycardia. Which of the following is the best initial step in management for this patient?
- A. Normal saline and insulin
- B. Insulin and potassium
- C. Normal saline and potassium
- D. Normal saline, insulin, and potassium (Correct Answer)
- E. Normal saline, insulin, potassium, and sodium bicarbonate
Endocrine drugs (insulin, thyroid medications) Explanation: ***Normal saline, insulin, and potassium***
- This patient presents with signs and symptoms consistent with **diabetic ketoacidosis (DKA)**, including hyperglycemia (glucose 599 mg/dL), metabolic acidosis (HCO3- 9 mEq/L, respiratory compensation with elevated respiratory rate), and altered mental status. The initial management of DKA involves aggressive **intravenous fluid resuscitation** (normal saline), **insulin administration** to correct hyperglycemia and acidosis, and **potassium replacement** due to total body potassium depletion and anticipated further drop with insulin therapy.
- Her **hypokalemia (2.9 mEq/L)**, even before insulin administration, necessitates immediate potassium repletion as insulin drives potassium intracellularly, which could worsen hypokalemia and lead to arrhythmias.
*Normal saline and insulin*
- While fluid resuscitation and insulin are crucial for DKA management, omitting **potassium replacement** in a patient with initial hypokalemia (K+ 2.9 mEq/L) would be inappropriate and potentially dangerous.
- Failure to correct hypokalemia before or with insulin administration can precipitate life-threatening **cardiac arrhythmias**.
*Normal saline, insulin, potassium, and sodium bicarbonate*
- **Sodium bicarbonate** is generally not recommended for DKA unless pH is extremely low (typically <6.9), as it can worsen cerebral edema and hypokalemia. The patient's bicarbonate of 9 mEq/L and presumably higher pH does not warrant bicarbonate administration.
- While fluids, insulin, and potassium are essential, the addition of sodium bicarbonate is usually reserved for severe, life-threatening acidosis (pH < 6.9).
*Normal saline and potassium*
- Administering only normal saline and potassium would address dehydration and hypokalemia but would fail to correct the underlying **hyperglycemia** and **ketoacidosis**, which are the core pathologies of DKA.
- **Insulin** is critical to stop ketogenesis and lower blood glucose.
*Insulin and potassium*
- Administering insulin and potassium without **fluid resuscitation** would be inadequate. The patient is likely significantly dehydrated due to osmotic diuresis from hyperglycemia and vomiting.
- **Fluid administration** is paramount in restoring circulating volume, improving renal perfusion, and reducing hyperglycemia by enhancing glucose excretion.
Endocrine drugs (insulin, thyroid medications) US Medical PG Question 4: An investigator is studying a drug that acts on the thyroid hormone pathway. Levels of serum free T3 and T4 in healthy participants are measured before and after administration of the drug. After administration, there is a decrease in the average serum free T3 level, while the average serum free T4 level is increased compared to initial serum studies. Inhibition of which of the following is the most likely mechanism of action of this drug?
- A. Thyroid-stimulating hormone
- B. Follicular iodotyrosine deiodinase
- C. Follicular thyroid peroxidase
- D. Peripheral 5'-deiodinase (Correct Answer)
- E. Follicular thyroid proteases
Endocrine drugs (insulin, thyroid medications) Explanation: ***Peripheral 5'-deiodinase***
- Inhibition of **peripheral 5'-deiodinase** would decrease the conversion of **T4 to T3** in the periphery, resulting in lower **free T3** and higher **free T4** levels.
- This enzyme is crucial for activating T4 into the more potent T3, and its blockade explains the observed changes in hormone levels.
*Thyroid-stimulating hormone*
- Inhibition of **TSH** would lead to a decrease in the production and release of both **T3 and T4** from the thyroid gland.
- This contradicts the observed increase in **free T4** levels.
*Follicular iodotyrosine deiodinase*
- This enzyme is involved in recycling iodine from **monoiodotyrosine (MIT)** and **diiodotyrosine (DIT)** within the thyroid follicular cells, which is important for efficient thyroid hormone synthesis.
- Its inhibition would primarily affect iodine availability and synthesis, not directly lead to increased T4 and decreased T3 in the periphery.
*Follicular thyroid peroxidase*
- **Thyroid peroxidase (TPO)** is critical for the **iodination of tyrosine residues** on thyroglobulin and the **coupling of MIT and DIT** to form T3 and T4.
- Inhibition of TPO would decrease the synthesis of both **T3 and T4**, contrary to the observed increase in **free T4**.
*Follicular thyroid proteases*
- **Thyroid proteases** cleave thyroglobulin to release mature **T3 and T4** into the bloodstream.
- Inhibition of these proteases would lead to a decrease in the release of both **T3 and T4**, which does not align with the observed increase in **free T4**.
Endocrine drugs (insulin, thyroid medications) US Medical PG Question 5: A 44-year-old woman presents to her physician’s office for weakness. She reports having some difficulty placing books on a high shelf and getting up from a seated position. She denies muscle pain or any new rashes. She has noticed a tremor that is worse with action and has been having trouble falling asleep and staying asleep. She has lost approximately 10 pounds unintentionally over the course of 2 months. Medical history is significant for type I diabetes mellitus managed with an insulin pump. Family history is notable for systemic lupus erythematosus in her mother and panic disorder in the father. Her temperature is 98.6°F (37 °C), blood pressure is 140/85 mmHg, pulse is 102/min, and respirations are 17/min. On physical exam, she is mildly diaphoretic and restless, she has notable lid retraction, and her hair is thin. She has 4/5 strength in the proximal upper and lower extremities. Biceps and patellar tendon reflexes are 3+. Which of the following laboratory findings are most likely present in this patient?
- A. Anti-Mi-2 antibody positivity
- B. Decreased thyroid-stimulating hormone (Correct Answer)
- C. Anti-nuclear antibody positivity
- D. Increased erythrocyte sedimentation rate
- E. Normal laboratory results
Endocrine drugs (insulin, thyroid medications) Explanation: **Decreased thyroid-stimulating hormone**
- The patient exhibits classic symptoms of **hyperthyroidism**, including unintended weight loss, heat intolerance (diaphoresis), fine tremor, insomnia, tachycardia (pulse 102/min), and proximal muscle weakness. Lid retraction and thin hair are also characteristic signs.
- In primary hyperthyroidism, the excessive production of thyroid hormones (T3 and T4) by the thyroid gland suppresses the pituitary's release of TSH, leading to a **decreased TSH level**.
*Anti-Mi-2 antibody positivity*
- **Anti-Mi-2 antibodies** are specific to **dermatomyositis**, which typically presents with a characteristic dermatological rash (e.g., heliotrope rash, Gottron papules) in addition to proximal muscle weakness. The patient explicitly denies new rashes.
- While proximal weakness is present, the absence of skin findings and the presence of significant hyperthyroid symptoms make dermatomyositis less likely.
*Anti-nuclear antibody positivity*
- **Anti-nuclear antibodies (ANAs)** are often positive in **autoimmune connective tissue diseases** like systemic lupus erythematosus (SLE), Sjogren's syndrome, and scleroderma. While the mother had SLE, the patient's constellation of symptoms points more directly to thyroid dysfunction.
- While ANA can be positive in autoimmune thyroid disease, it's not the most direct or specific laboratory finding for the dominant clinical picture presented.
*Increased erythrocyte sedimentation rate*
- An **increased ESR** is a non-specific marker of **inflammation** and can be elevated in various conditions, including infections, autoimmune diseases, and certain cancers.
- While ESR can be elevated in some cases of hyperthyroidism, it is not as specific or as direct a diagnostic marker for the condition as thyroid hormone levels themselves.
*Normal laboratory results*
- Given the clear and numerous signs and symptoms of a pathological process, particularly **hyperthyroidism**, it is highly unlikely that all laboratory results would be normal.
- The constellation of symptoms like weight loss, tremor, palpitations, insomnia, and muscle weakness strongly indicates a significant underlying medical condition requiring laboratory investigation.
More Endocrine drugs (insulin, thyroid medications) US Medical PG questions available in the OnCourse app. Practice MCQs, flashcards, and get detailed explanations.
